Sun Pharma to acquire Organon for Inorganic Growth - The Financial World
Sun Pharma→Organon
May 1, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Vitalist has completed the acquisition of Somatix, a home health business in Alberta, for $12.3 million. Vitalist acquires Somatix to expand into AI-powered remote patient monitoring and medical wearables, integrating Somatix capabilities into the VitalOS smartwatch ecosystem. Somatix provides passive gesture detection and healthcare algorithms that support remote care delivery for patients and providers. The healthcare M&A is a strategic acquisition and merger acquisition that closed in 2026, with Vitalist issuing consideration shares and appointing Dr. Charles Herman as Chief Science Officer and Nick Padula as Chief Revenue Officer to accelerate commercialization.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
May 1, 2026
Vireo Growth→Fluent
May 1, 2026
United Surgical Partners International→ASCs (seven acquired)
Apr 30, 2026
Volaris Group→Interplayers
Apr 30, 2026
Tenet Healthcare→United Surgical Partners International
Apr 30, 2026